New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - Blood, 2004 - ashpublications.org
When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY)
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
[引用][C] New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P SODANI, D GAZIEV, B LUCARELLI, RA CLIFT… - Blood, 2004 - pascal-francis.inist.fr
New approach for bone marrow transplantation in patients with class 3 thalassemia aged
younger than 17 years CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
younger than 17 years CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[引用][C] New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P SODANI - Blood, 2004 - cir.nii.ac.jp
New approach for bone marrow transplantation in patients with class 3 thalassemia aged
younger than 17 years | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
younger than 17 years | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years.
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - Blood, 2004 - europepmc.org
When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY)
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - …, 2004 - pubmed.ncbi.nlm.nih.gov
When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY)
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
[PDF][PDF] New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - BLOOD, 2004 - researchgate.net
Beta thalassemia is a genetic disorder resulting in absent or reduced beta globin chain
synthesis producing hemolytic anemia. Patients are treated with red blood cell transfusions …
synthesis producing hemolytic anemia. Patients are treated with red blood cell transfusions …
[PDF][PDF] New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - BLOOD, 2004 - academia.edu
Beta thalassemia is a genetic disorder resulting in absent or reduced beta globin chain
synthesis producing hemolytic anemia. Patients are treated with red blood cell transfusions …
synthesis producing hemolytic anemia. Patients are treated with red blood cell transfusions …
[HTML][HTML] New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - Blood, 2004 - Elsevier
When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY)
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years …
[PDF][PDF] New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
P Sodani, D Gaziev, P Polchi, B Erer, C Giardini… - BLOOD, 2004 - academia.edu
Beta thalassemia is a genetic disorder resulting in absent or reduced beta globin chain
synthesis producing hemolytic anemia. Patients are treated with red blood cell transfusions …
synthesis producing hemolytic anemia. Patients are treated with red blood cell transfusions …